We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Rituximab was both effective and safe in HIV-infected patients with chemotherapy-dependent MCD.
No takes yet. Share an insight, caveat, or question.
Gérard et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: